Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Pediatric Infect Dis Soc. 2024 Feb 28;13(Supplement_1):S80-S89. doi: 10.1093/jpids/piad062.
The microbial communities that inhabit our bodies have been increasingly linked to host physiology and pathophysiology. This microbiome, through its role in colonization resistance, influences the risk of infections after transplantation, including those caused by multidrug-resistant organisms. In addition, through both direct interactions with the host immune system and via the production of metabolites that impact local and systemic immunity, the microbiome plays an important role in the establishment of immune tolerance after transplantation, and conversely, in the development of graft-versus-host disease and graft rejection. This review offers a comprehensive overview of the evidence for the role of the microbiome in hematopoietic cell and solid organ transplant complications, drivers of microbiome shift during transplantation, and the potential of microbiome-based therapies to improve pediatric transplantation outcomes.
我们体内栖息的微生物群落与宿主生理学和病理生理学的关系日益密切。该微生物组通过其在定植抗性中的作用,影响移植后的感染风险,包括多药耐药菌引起的感染。此外,通过与宿主免疫系统的直接相互作用以及通过产生影响局部和全身免疫的代谢产物,微生物组在移植后免疫耐受的建立中发挥重要作用,反之,在移植物抗宿主病和移植物排斥反应的发展中也发挥重要作用。这篇综述全面概述了微生物组在造血细胞和实体器官移植并发症中的作用的证据,移植过程中微生物组变化的驱动因素,以及基于微生物组的治疗方法改善儿科移植结果的潜力。